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In the present work, a recombinant Escherichia coli strain was used for the production of interferon α-2b in both 
shake flask and in bioreactor. The first part of this research was focused on the investigation of the effect of 
glucose concentration on the kinetics of cell growth, recombinant protein production and acetate formation. In 
general, glucose supplementation to culture medium enhanced cell growth when added in concentration between 
0-20 g/L. Further increase in glucose level reduces biomass production and enhances acetate accumulation in 
culture. The results clearly demonstrated that maximal interferon production of 27.7 mg/L was achieved in 
culture supplemented with 20 g/L glucose. Further improvement in recombinant interferon production process 
was also achieved by scaling up from shake flask to 16-L stirred tank bioreactor. The maximal volumetric 
interferon production in bioreactor batch culture was 44.5. mg/L after only 6 hours.  
  
Key words:  
rEscharichia coli, interferon 
α-2b, batch cultivation, 
glucose effect, bioreactor 
cultivation. 
  
INTRODUCTION 
 
For many years Escherichia coli acts as industrially 
important microorganisms in health industries. This bacteria can 
produce pharmaceutically important enzymes in both antibiotic 
industries such as penicillin acylase (El Enshasy et al., 2009, 
Mohy El deenet al., 2012) and biotherapeutic enzymes for cancer 
treatment like asparaginase (Swain et al., 1993). Moreover, since 
the revolution of recombinant DNA technology in the mid-1970s, 
E. coli became one of the main protein biofactories for 
biopharmaceutical protein production in wellness industries 
(Sarmidi and Elenshasy, 2012). Since that time E. coli showed 
high potential for different recombinant protein production and 
enzymes such as -glucanase (Beshayet al., 2011), human           
growth hormones (Castanet al., 2002), Insulin (Schmidt et al., 
1999);  Viral surface  antigen  (Abbas et al., 2007),  and  Hirudin 
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 (Lu et al., 2013). The superiority of E. coli over other Prokaryotic 
and Eukaroytic hosts was based on its higher growth rate, cheap 
cultivation medium and better understood of the genetic, molecular 
biology and cultivation strategies of this microorganism. It showed 
also high potential for interferon production in laboratory and semi-
industrial scale (Luz et al., 2007).  
Of different pharmaceutically important recombinant 
biotherapeutic proteins, interferons (IFs) are glycoprotein cytokines 
family with particular importance based on their bioactivities as 
antiviral, anti-proliferative and immunomodulator agent. Based on 
their wide applications in the treatment of epidemic diseases such 
as HepB and HepC viruses, the interferons market expect to exceed 
US$ 10-Billions by 2015 according to the recent interferon market 
forecast study (Interferon Market Forecast 2015). The level of 
expression of the desired protein is highly regulated not only by the 
plasmid expression system and stability but also by the cultivation 
condition and medium composition. The cultivation medium for 
recombinant protein production using E. coli includes mainly 
glucose as sole carbon source. During cultivation, the cells utilize 
glucose   for   growth   and   protein   production  and produce some  
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undesired by products such as lactate and acetate. These two 
compounds can act as inhibitors for cell growth and recombinant 
protein production. Thus, it is necessary to optimize glucose 
concentration in batch culture for better cell growth and 
recombinant protein induction. Thus, the main objective of this 
work was to study of the effect of initial glucose concentration on 
the kinetics of cell growth, interferon α-2b production. Based on 
the obtained results, cultivations were also conducted in bioreactor 
level to investigate the effect of production scale on the kinetics of 
cell growth and recombinant protein production.  
 
MATERIALS AND METHODS 
 
Microorganism  
The original strain a non-pathogenic Escherichia coli K-
12 (ATCC 10798) was initially obtained from American Type 
Culture Collection (ATCC, Manassas, VA, USA). This strain was 
genetically modified to produce a recombinant strain of rE. coli 
with a plasmid coding Egyferon 4457bp for recombinant human 
interferon α-2b production. The recombinant strain was preserved 
in frozen in 50% glycerol solution (v/v) at -80 °C. Before use, the 
cells were activated twice in LB agar medium of the following 
composition (g/L): beef extract 5, peptone 10, yeast extract 5, 
NaCl 5, and agar 20 (pH 7.0). After 24 h day cultivation, the arisen 
colonies were used to inoculate 250-ml Erlenmeyer flask (of 50 ml 
working volume) containing LB broth. The inoculated flasks were 
incubated on rotary shaker at 37°C and 200 rpm for 24 h.  
 
Inoculum preparation  
Inoculum was prepared in a 250 ml Erlenmeyer flask 
containing 50 ml YPM medium composed of (g/L): yeast extract, 
5, peptone, 3 and mannitol, 25. After sterilization for 15 min at 
121°C, 50 ml YPM medium was inoculated with 250 μl of 
glycerol culture. The inoculated flasks were incubated on the 
rotary shaker (Innova 4080, New Brunswick Scientific Co., NJ, 
USA) at 200 rpm and 37°C for 24 h. Cells were used thereafter to 
inoculate either 250 ml Erlenmeyer flasks or stirred tank 
bioreactor with inoculum concentration of 10% (v/v). 
 
Fermentation medium 
The medium used for interferon production had the 
following composition (g/L): yeast extract, 10; NaCl, 2.5; 
Tryptone, 20; MgSO4.7H2O, 0.12 and pH 7.0. Glucose was 
sterilized separately and added to the fermentation medium before 
inoculation. In case of shake flask, cultivations were carried our 
using 250 ml Erlenmeyer flask with a working volume of 50 ml 
and inoculated with cells grown for 24 h in vegetative medium as 
described previously in concentration of 10% (v/v). The inoculated 
flasks were incubated on rotary shaker at 200 rpm and 37 °C for 
the first 2 hours and then temperature increased up to 42 °C for the 
rest of cultivation time.  
 
Bioreactor cultivations  
Cultivation in stirred tank bioreactor were conducted 
using the same medium in shake flask level (supplemented with 
glucose 20 g/L) and run under the same cultivation conditions in 
term of inoculums size, temperature and pH. The bioreactor used 
in this study was 16-L stirred tank bioreactor (Bio-Engineering, 
Wald, Switzerland) with working volume of 8-L. The stirrer was 
equipped with two 6-blade Rushton turbine impellers (di (impeller 
diameter) = 85 mm; dt (tank diameter) = 214 mm, di/dt = 0.397). 
The agitation speed was adjust to 600 rpm and kept constant 
throughout the cultivation and aeration was performed using 
filtered sterile air and supplied continuously to the bioreactor with 
rate of 0.5 v/v/min. Foam was suppressed by the addition of 
silicon antifoam grade A (Sigma-Aldrich Inc., MO, USA). During 
the cultivation process, pH value and dissolved oxygen 
concentration were determined using pH and DO polarographic 
electrodes, respectively (Ingold, Mettler-Toledo, Switzerland). The 
pH was adjusted to 7.0 by cascading the pH controller with 
acid/base feeding peristaltic pumps connected with 4 M HCl and 4 
M NaOH solutions. 
 
Sample preparation and cell dry weight determination  
Samples, in form of two flasks containing 50 ml each, or 
25 ml of broth in case of bioreactor, were withdrawn at different 
times during the cultivation in a centrifugation falcon tube (Falcon, 
USA). Immediately after sampling, the optical density was 
measured by using spectrophotometer (Novaspec II, Pharmacia 
Biotech, Sweden) at 600 nm after proper dilution. For all samples, 
the cultivated broth was diluted to give values less than (1 OD600) 
for better accuracy. The OD of culture was converted to dry cell 
mass through a linear correlation standard curve. Based on 
standard curve of this strain, One OD600 was almost equivalent to 
0.28 g/L. 
 
Glucose, lactate and acetate determination 
Glucose and lactate concentrations were determined 
using automatic glucose/lactate analyzer (YSI 2700, Yellow 
Springs Instruments, OH, USA). The measurement is based on a 
coupled enzymatic-electrochemical process in which the enzyme 
(glucose oxidase or lactate oxidase) is immobilized between two 
membrane layers, polycarbonate and cellulose acetate. The 
substrate is oxidized at the immobilized oxidase layer producing 
hydrogen peroxide, which then passes through the cellulose 
acetate membrane to interact with the platinum anode 
(Pt/AgCl/Ag) producing electrons. The electron flow is 
proportional to the H2O2 concentration and, therefore, to substrate 
concentration. Acetate was assayed according to the method of 
Pecinaet al. (1984) which was modified later by Tomlinset al. 
(1990) using HPLC system (Waters, Milford, MA, USA). This 
system composed of a pump Waters 600 controller, 2690 
Separation Module HPLC (Model 2690, Waters, Milford, MA, 
USA) and auto sampler fitted with a detection system; Ultraviolet 
(UV) 2487 Dual Absorbance Detector at 210 nm (Water, Milford, 
MA USA). Separation was carried out using organic acid column: 
300×7.8 mm/ 8 micron (Phenomenex, Torrance, USA) was used to 
achieve the chromatographic separations. Acetic acid was eluted 
with 0.005N. sulphuric acid at a flow rate of 0.5 ml/min at 40 °C. 
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Peak heights were measured using a dual channel computer 
integrator (Water Empower chromatography system, Waters, 
Milford, MA, USA) and converted to acetic acid concentration 
based on previously prepared standard. 
 
RESULTS AND DISCUSSION 
 
Effect of glucose concentration on kinetics of cell growth and 
recombinant interferon production  
The aim of this experiment was to study the influence of 
glucose concentration on cell growth kinetics and interferon 
production. Thus, the recombinant strain of E. coli was used to 
inoculate different media of different glucose concentrations from 
0 to 30 g/L glucose. The inoculated flasks were incubated 
simultaneously on rotary shaker of 200 rpm. The initial cultivation 
temperature for all cultures were set at 37 °C during the first 2 
hours of cultivation and increased thereafter up to 42 °C to induce 
recombinant protein production.  
 
 
Fig. 1: Changes in cell growth, interferon α-2b production and pH during batch 
cultivation of rE. coli in shake flask level at different glucose concentrations 
(□, 0 g/L; ■, 5 g/L; ●, 10 g/L; ▲, 15 g/L; ▼, 20 g/L; ♦, 25 g/L; ◊, 30 g/L). 
Values are mean ± standard deviation, n=2.  
 
Figure 1 demonstrates the dynamic profile of rE.coli growth, 
interferon production and pH during batch cultivation at various 
levels of glucose concentration (0-30 g/L). As shown, cell growth 
was enhanced by glucose concentration in range between (0-20 
g/L). Further increase in glucose concentration suppresses cell 
growth. The maximal biomass of about 1.7g/L in 20 g/L glucose 
supplemented culture after 7 hours. On the other hand, the 
expression of interferon in culture was enhanced by addition of 
glucose to culture medium. The rate of interferon production in 
culture increased from 2.14 mg/L/h in glucose free medium to 
about 5.54 mg/L/h in 20 g/L glucose supplemented medium. The 
maximal value of volumetric interferon production of 27.7 mg/L 
was obtained in 20 g/L glucose supplemented culture. However, in 
all medium formulations, the pH dropped gradually during cell 
growth phase and kept more or less constant for the rest of 
cultivation time. As shown in figure 1, direct proportional relation 
was observed between the glucose concentration applied and the 
drop of the pH in culture. The minimal value of pH of about 4.25 
was observed in 30 g/L supplemented culture after 8 hours. 
Effect of glucose concentration on acetate formation  
Figure 2 demonstrates the change in glucose and acetate 
concentrations during batch cultivation of rE.coli in shake flask 
level. As shown, glucose was fully consumed in culture 
supplemented with range between 0-20 g/L. In cultures more than 
20 g/L, glucose was still available in culture after 8 days 
cultivation. On the other hand, acetate formation was also 
followed in this culture to investigate the relation between initial 
glucose concentration in medium and acetate formation. It was 
observed that, no acetate was formed in glucose free culture and 
the amount of acetate produced was directly proportional to the 
initial glucose concentration.  
 
 
Fig. 2: Glucose consumption and acetate production during batch cultivation of 
recombinant rE. coli in shake flask level at different glucose concentrations (□, 
0 g/L; ■, 5 g/L; ●, 10 g/L; ▲, 15 g/L; ▼, 20 g/L; ♦, 25 g/L; ◊, 30 g/L). Values 
are mean ± standard deviation, n=2.  
 
The maximal acetate formation of 360 mg/L was obtained in 30 
g/L glucose supplemented culture. Thus, we can also conclude that 
the drop in medium pH (figure 1) is directly related to the acetate 
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formation in culture as the lowest pH was also recorded in culture 
of high glucose concentration. Based on all these data together (in 
figures 1 and 2), we can conclude that glucose in concentration of 
20 g/L is optimum for interferon production and thus this 
concentration was used in bioreactor experiment. 
 
Kinetics of cell growth and interferon production in stirred 
tank bioreactor under controlled pH condition 
Based on the results of shake flasks, cultivations were 
conducted in 16-L stirred tank bioreactor to investigate the 
scalability of this process. Inoculum size and medium composition 
were the same as in shake flask culture. As show in figure 3, cells 
grew exponentially with growth rate of 0.31 g/L/h reaching a 
maximal cell mass of about 1.9 g/L after 6 h. During that time, 
dissolved oxygen decreased gradually as a function of cell growth 
but was not limited during the all stages of cultivations. During the 
exponential growth phase, glucose consumed in culture with rate 
of 3.25 g/L/h and was limited in culture after 7 h cultivation. For 
recombinant protein production, interferon induction was first 
induced in culture after 2 h by increasing the cultivation 
temperature from 37 °C to 42 °C. After this temperature shift, 
interferon produced in culture with rate of about 10.5 mg/L/h and 
reached a maximal value of 44.5 mg/L after only 6 hours.  
 
 
Fig. 3: Changes in cell growth, interferon α2b production, glucose and acetate 
concentration during cultivation of rE.coli in 16-L stirred tank bioreactor 
(values are mean ± standard deviation, n=2).  
 
The significant increase in the interferon production rate in case of 
bioreactor culture was due to the better mixing (aeration/agitation) 
compared to shake flask. In addition, the control of induction 
temperature is more easy and accurate in bioreactor compared to 
shake flask. These together results in the increase in metabolic 
activities and recombinant protein expression in case E. coli. 
However, table 1 shows clear comparison between the kinetics of 
cell growth, substrate consumption, acetate production, and 
interferon production for better understanding of the improvement 
done in this study by process transfer from shake flask to 
bioreactor.  
 
Table. 1: Different growth and production parameters during interferon 
production by rE.coli in shake flask and bioreactor cultures in production 
medium supplemented with 20 g/L glucose. 
 Xmax 
[g/L] 
dx/dt 
[g/L/h] 
 
[1/h] 
ds/dt 
[g/L/h] 
Pmax 
[mg/L] 
dp/dt 
[mg/L/h] 
Yp/x 
[mg/g] 
Actmax 
[mg/L] 
dAc/dt 
[mg/L.h] 
SF 1.7 0.31 0.39 2.31 27.7 5.54 16.3 195 63.5 
BR 1.9 0.31 0.31 3.33 44.5 10.48 23.4 225 45.0 
 
Xmax, maximal cell growth; dx/dt, growth rate; , specific growth 
rate; ds/dt, glucose consumption rate; Pmax, maximal volumetric 
interferon production; Yp/x, specific interferon production; Actmax, 
maximal acetate concentration; dAc/dt, acetate production rate.  
Thus, it is clearly observed that, bioprocess transfer from 
shake flask to bioreactor increased the volumetric interferon 
production by about 61%. However, not only the volumetric 
production increased but also the specific interferon production 
Yp/x was increased by about 44%. Thus, we can conclude that the 
observed increase in interferon production in bioreactor is not only 
due to the increase in biomass but mainly due to the increase in 
cell performance. This was also indicated by higher glucose 
consumption rate in bioreactor which was higher by about 44% 
compared to shake flask cultures. On the other hand, the rate of 
acetate production was less in bioreactor compared to shake flask 
by about almost about 41%.  
 
CONCLUSION 
 
Considering the results achieved, we can conclude that 
the initial glucose concentration in culture medium have 
significant influence on the cell growth and expression of 
recombinant protein in E. coli understudy. The maximal interferon 
production was achieved in 20 g/L glucose supplemented culture. 
In addition, cultivation in semi-industrial scale 16-L bioreactor 
showed not only significant improvement in growth and 
production kinetics but also decrease the production of the 
undesired metabolites such as acetate. Further studies on 
bioprocess improvement using different fed-batch cultivation 
strategies to increase interferon production in bioreactor level are 
under study in our laboratories.  
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